Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$12.93 - $18.05 $214,935 - $300,045
16,623 Added 89.22%
35,255 $466,000
Q1 2023

May 08, 2023

SELL
$13.02 - $22.62 $885 - $1,538
-68 Reduced 0.36%
18,632 $254,000
Q4 2022

Feb 14, 2023

SELL
$17.77 - $21.6 $5,331 - $6,480
-300 Reduced 1.58%
18,700 $365,000
Q2 2022

Aug 12, 2022

BUY
$16.57 - $35.1 $314,830 - $666,900
19,000 New
19,000 $392,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.